Akt-I-1 ≥95%

Supplier: ADIPOGEN CORP MS

SYN-1005-M005 SYN-1005-M010 SYN-1005-M001
102991-294EA 904.15 USD
102991-294 102991-202 102991-204
Akt-I-1 ≥95%
Akt-I-1

The compound (Akt-I-1) inhibits only Akt1 (IC(50) 4.6 µM) and does not inhibit AKT2, or AKT3. The compound is a reversible inhibitor, and exhibits a linear mixed-type inhibition against ATP and peptide substrate. In addition to inhibiting kinase activity of AKT1 isoform, AKT-I-1 blocked the phosphorylation and activation of AKT1 by PDK1 (phosphoinositide-dependent kinase 1). The inhibitor was found to be cell-active and to block phosphorylation of Akt at Thr308 and Ser473, reduce the levels of active Akt in cells, block the phosphorylation of known Akt substrates and promote TRAIL (tumour-necrosis-factor-related apoptosis-inducing ligand)-induced apoptosis in LNCap prostate cancer cells.

Formula: C₂₂H₃₀N₆
Storage Temperature: Freezer
MDL Number: MFCD16038643
CAS Number: 473382-39-7

Order Now

Specification Test Results

Purity 95%
Appearance/Color Solid.
Solubility Soluble in DMSO.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR